Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISTAL-UK trial of intra-arterial urokinase for acute ischemic stroke without large or medium vessel occlusion
ChiCTR2400081660Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Mar 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of urokinase in ischemic stroke (2 arms), sponsored by Xinqiao Hospital. Primary endpoints: Modified Rankin Scale score 0-1, Symptomatic intracranial hemorrhage and 1 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
urokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400081660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081660.